Researchers at the University of California San Diego School of Medicine report that treating patients with personalized, combination therapies improved outcomes in patients with therapy resistant cancers. Their study (“Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study”) appears online in Nature Medicine. “Cancer treatments have evolved from indiscriminate cytotoxic agents to selective genome- and […]
The post Personalized, Combination Therapies Improve Cancer Patient Outcomes appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Personalized, Combination Therapies Improve Cancer Patient Outcomes